Clinical Trial

Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria

Name: Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria — clinical trial record (NCT07345923)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SCREEN ICU

Recruiting

View on ClinicalTrials.gov →

Summary

The objective of the research is to evaluate the value of testing for ESBL carriage by rectal swab to predict the risk of ESBL-producing Enterobacteriaceae infections in intensive care.

Trial Details

NCT Number	NCT07345923
Lead Sponsor	University Hospital, Strasbourg, France
Conditions	Infections, Enterobacteriaceae
Enrollment	1,000 participants
Start Date	2025-10-06
Primary Completion	2027-04 (estimated)
Study Completion	2027-04 (estimated)
Updated on ClinicalTrials.gov	2026-01-16